应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
AMGN 安进
盘前交易 05-01 05:08:00 EDT
290.92
+2.36
+0.82%
盘前
290.90
-0.02
-0.01%
05:05 EDT
最高
292.00
最低
286.09
成交量
261.23万
今开
289.44
昨收
288.56
日振幅
2.05%
总市值
1,564亿
流通市值
1,560亿
总股本
5.38亿
成交额
7.57亿
换手率
0.49%
流通股本
5.36亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
安进4月30日成交额为7.58亿美元
市场透视 · 01:15
安进4月30日成交额为7.58亿美元
安进4月28日成交额为5.89亿美元
市场透视 · 04-29 01:15
安进4月28日成交额为5.89亿美元
安进宣布投资9亿美元扩建俄亥俄州生产基地,新增350个工作岗位
药事纵横 · 04-27
安进宣布投资9亿美元扩建俄亥俄州生产基地,新增350个工作岗位
安进拟斥9亿美元扩建美国俄亥俄州工厂
格隆汇APP · 04-27
安进拟斥9亿美元扩建美国俄亥俄州工厂
安进4月25日成交额为5.59亿美元
市场透视 · 04-26
安进4月25日成交额为5.59亿美元
安进4月22日成交额为5.77亿美元
市场透视 · 04-23
安进4月22日成交额为5.77亿美元
安进4月21日成交额为4.94亿美元
市场透视 · 04-22
安进4月21日成交额为4.94亿美元
安进4月15日成交额为7.64亿美元
市场透视 · 04-16
安进4月15日成交额为7.64亿美元
安进4月14日成交额为7.28亿美元
市场透视 · 04-15
安进4月14日成交额为7.28亿美元
瑞银:维持Amgen(AMGN.US)评级,由中性调整至中性评级, 目标价由315.00美元调整至319.00美元。
金融界 · 04-14
瑞银:维持Amgen(AMGN.US)评级,由中性调整至中性评级, 目标价由315.00美元调整至319.00美元。
安进盘中异动 股价大涨3.03%报334.69美元
市场透视 · 03-10
安进盘中异动 股价大涨3.03%报334.69美元
【安进:Rocatinlimab治疗中重度特应性皮炎研究达到共同主要终点】 3月8日,安进公司与协和麒麟株式会社公布了ROCKET III期临床试验项目的最新结果。该项目正在评估rocatinlimab用于治疗中重度特应性皮炎的疗效。IGNITE研究评估了rocatinlimab的两种剂量强度,达到了共同主要终点和所有关键次要终点,两种剂量组相较于安慰剂组均显示出统计学显著差异。
金融界 · 03-08
【安进:Rocatinlimab治疗中重度特应性皮炎研究达到共同主要终点】 3月8日,安进公司与协和麒麟株式会社公布了ROCKET III期临床试验项目的最新结果。该项目正在评估rocatinlimab用于治疗中重度特应性皮炎的疗效。IGNITE研究评估了rocatinlimab的两种剂量强度,达到了共同主要终点和所有关键次要终点,两种剂量组相较于安慰剂组均显示出统计学显著差异。
医药生物行业专题:海外制药企业2024Q4&全年业绩回顾
国信证券股份有... · 03-07
医药生物行业专题:海外制药企业2024Q4&全年业绩回顾
安进(AMGN.US)AMG 133启动减重III期临床
智通财经 · 03-07
安进(AMGN.US)AMG 133启动减重III期临床
首个肿瘤mRNA疫苗有望在2027年推出;安进减肥药启动III期临床
Ofweek光电信息网 · 03-07
首个肿瘤mRNA疫苗有望在2027年推出;安进减肥药启动III期临床
每月1针!安进AMG 133启动减重III期临床
医药魔方 · 03-06
每月1针!安进AMG 133启动减重III期临床
美银证券分析师:强生等五支生物制药股可能会蓄势突破
老虎资讯综合 · 03-06
美银证券分析师:强生等五支生物制药股可能会蓄势突破
B of A Securities:维持Amgen(AMGN.US)评级,由低于大市调整至低于大市评级, 目标价由275.00美元调整至294.00美元。
金融界 · 03-05
B of A Securities:维持Amgen(AMGN.US)评级,由低于大市调整至低于大市评级, 目标价由275.00美元调整至294.00美元。
百济神州,正在走安进曾经的路
医曜 · 02-27
百济神州,正在走安进曾经的路
安进盘中异动 股价大跌3.00%报306.15美元
市场透视 · 02-26
安进盘中异动 股价大跌3.00%报306.15美元
公司概况
公司名称:
安进
所属市场:
NASDAQ
上市日期:
--
主营业务:
安进公司于1980年在加利福尼亚成立,并于1987年成为特拉华州的一家公司。该公司发现、开发、制造和交付创新药物,以对抗世界上一些最棘手的疾病。该公司专注于高度未满足的医疗需求领域,并利用其专业知识努力寻求能够显著改善人们生活的解决方案,同时还能减轻疾病带来的社会和经济负担。该公司在40多年前帮助启动了生物技术产业,并已成长为世界领先的独立生物技术公司之一。
发行价格:
--
{"stockData":{"symbol":"AMGN","market":"US","secType":"STK","nameCN":"安进","latestPrice":290.92,"timestamp":1746043200000,"preClose":288.56,"halted":0,"volume":2612306,"hourTrading":{"tag":"盘前","latestPrice":290.9,"preClose":290.92,"latestTime":"05:05 EDT","volume":217,"amount":63010.281319999995,"timestamp":1746090339091},"delay":0,"floatShares":536285636,"shares":537650624,"eps":7.56,"marketStatus":"盘前交易","change":2.36,"latestTime":"05-01 05:08:00 EDT","open":289.44,"high":292,"low":286.09,"amount":756668121.38344,"amplitude":0.020481,"askPrice":290.9,"askSize":88,"bidPrice":251.58,"bidSize":100,"shortable":3,"etf":0,"ttmEps":7.56,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1746106200000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":423288000000,"exchange":"NASDAQ","adjPreClose":290.92,"dividendRate":0.031383,"preHourTrading":{"tag":"盘前","latestPrice":290.9,"preClose":290.92,"latestTime":"05:05 EDT","volume":217,"amount":63010.281319999995,"timestamp":1746090339091},"postHourTrading":{"tag":"盘后","latestPrice":288,"preClose":290.92,"latestTime":"19:59 EDT","volume":264591,"amount":76956124.16272,"timestamp":1746057566280},"volumeRatio":1.169875805291158,"impliedVol":0.3707,"impliedVolPercentile":0.759},"requestUrl":"/m/hq/s/AMGN/wiki","defaultTab":"wiki","newsList":[{"id":"2532901269","title":"安进4月30日成交额为7.58亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2532901269","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532901269?lang=zh_cn&edition=full","pubTime":"2025-05-01 09:15","pubTimestamp":1746062159,"startTime":"0","endTime":"0","summary":"美东时间2025年4月30日,安进成交额为7.58亿美元,成交额较昨日增加22.67%,当日成交量为261.23万股。安进于2025年4月30日涨0.82%,报290.92美元,该股过去5个交易日涨4.69%,年初至今涨12.52%,过去60日涨1.52%。安进于 2006 年推出了首款癌症治疗药物 Vectibix,并销售骨强化药物 Prolia/Xgeva和 Evenity。同时,安进还拥有不断增长的生物仿制药产品组合。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501091609a46e61e7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501091609a46e61e7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999001440.SGD","LU0868494617.USD","LU2242646821.SGD","BK4534","IE00BFTCPJ56.SGD","LU1023059063.AUD","LU2242652126.USD","BK4599","LU0058720904.USD","BK4588","BK4585","LU2112291526.USD","LU0289739699.SGD","LU2089984988.USD","LU1057294990.SGD","IE00BJT1NW94.SGD","LU1983299246.USD","LU1061106388.HKD","BK4581","LU2468319806.SGD","AMGN","BK4566","IE00B2B36J28.USD","BK4533","LU0320765992.SGD","IE0002141913.USD","LU1571399168.USD","IE00B4R5TH58.HKD","BK4139","IE0009355771.USD","LU0889565916.HKD","LU0122379950.USD","LU0109394709.USD","IE00BJJMRZ35.SGD"],"gpt_icon":0},{"id":"2531213559","title":"安进4月28日成交额为5.89亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531213559","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531213559?lang=zh_cn&edition=full","pubTime":"2025-04-29 09:15","pubTimestamp":1745889357,"startTime":"0","endTime":"0","summary":"美东时间2025年4月28日,安进成交额为5.89亿美元,成交额较昨日增加5.29%,当日成交量为208.25万股。安进于2025年4月28日涨0.8%,报283.09美元,该股过去5个交易日涨3.44%,年初至今涨9.49%,过去60日涨0.48%。安进于 2006 年推出了首款癌症治疗药物 Vectibix,并销售骨强化药物 Prolia/Xgeva和 Evenity。同时,安进还拥有不断增长的生物仿制药产品组合。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429091607a46b3b5b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429091607a46b3b5b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0289739699.SGD","LU2089984988.USD","AMGN","LU0122379950.USD","BK4139","SG9999001440.SGD","IE00B4R5TH58.HKD","IE00B2B36J28.USD","LU1023059063.AUD","LU0868494617.USD","LU1057294990.SGD","IE00BFTCPJ56.SGD","BK4533","BK4581","IE0009355771.USD","LU1571399168.USD","LU0889565916.HKD","BK4585","IE00BJJMRZ35.SGD","LU1061106388.HKD","LU0320765992.SGD","BK4599","LU2242652126.USD","BK4534","LU2112291526.USD","BK4588","IE00BJT1NW94.SGD","BK4566","LU0109394709.USD","LU2242646821.SGD","LU1983299246.USD","IE0002141913.USD","LU0058720904.USD","LU2468319806.SGD"],"gpt_icon":0},{"id":"2530454984","title":"安进宣布投资9亿美元扩建俄亥俄州生产基地,新增350个工作岗位","url":"https://stock-news.laohu8.com/highlight/detail?id=2530454984","media":"药事纵横","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530454984?lang=zh_cn&edition=full","pubTime":"2025-04-28 00:03","pubTimestamp":1745769792,"startTime":"0","endTime":"0","summary":"2025年4月25日,安进公司对外宣布,该公司将对其俄亥俄州生产基地追加9亿美元投资,使该州累计新增就业岗位达750个,在中俄亥俄州总投资额超过14亿美元。此次投资进一步彰显我们对扩大美国生产基地的承诺,确保全球患者能持续获得创新药物。\"安进于2021年6月首次进驻俄亥俄州,宣布在中俄亥俄州建设尖端生物制药基地。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428002754a4695b56&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428002754a4695b56&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1571399168.USD","LU1061106388.HKD","BK4581","LU0320765992.SGD","LU2089984988.USD","LU1023059063.AUD","LU0058720904.USD","LU2468319806.SGD","LU2242652126.USD","SG9999001440.SGD","LU0289739699.SGD","BK4534","IE00BFTCPJ56.SGD","BK4139","BK4585","IE0002141913.USD","LU0122379950.USD","BK4566","LU2112291526.USD","LU1983299246.USD","IE00BJJMRZ35.SGD","BK4533","LU1057294990.SGD","IE00B2B36J28.USD","BK4599","LU0889565916.HKD","LU0868494617.USD","LU0109394709.USD","LU2242646821.SGD","AMGN","IE00B4R5TH58.HKD","IE00BJT1NW94.SGD","IE0009355771.USD","BK4588"],"gpt_icon":0},{"id":"2530193102","title":"安进拟斥9亿美元扩建美国俄亥俄州工厂","url":"https://stock-news.laohu8.com/highlight/detail?id=2530193102","media":"格隆汇APP","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530193102?lang=zh_cn&edition=full","pubTime":"2025-04-27 11:08","pubTimestamp":1745723280,"startTime":"0","endTime":"0","summary":"格隆汇4月27日|制药公司安进周五表示,将投资9亿美元扩建美国俄亥俄州的制造工厂,料增加350个工作岗位。去年12月,安进宣布斥资10亿美元在北卡罗来纳州霍利斯普林斯建造第二间原料药厂。 \n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/bxjj/2025-04-27/doc-ineuqqcx0040528.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU1061106388.HKD","SG9999001440.SGD","LU1057294990.SGD","IE00BJJMRZ35.SGD","IE00B4R5TH58.HKD","LU1571399168.USD","AMGN","BK4585","IE00BFTCPJ56.SGD","LU0058720904.USD","LU0122379950.USD","BK4581","BK4534","LU2242646821.SGD","LU2242652126.USD","LU2112291526.USD","BK4566","IE0002141913.USD","BK4599","LU0109394709.USD","LU0320765992.SGD","LU1023059063.AUD","IE0009355771.USD","BK4139","LU1983299246.USD","IE00BJT1NW94.SGD","BK4533","LU2089984988.USD","LU2468319806.SGD","LU0289739699.SGD","LU0868494617.USD","LU0889565916.HKD","BK4588","IE00B2B36J28.USD"],"gpt_icon":0},{"id":"2530113678","title":"安进4月25日成交额为5.59亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530113678","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530113678?lang=zh_cn&edition=full","pubTime":"2025-04-26 09:15","pubTimestamp":1745630151,"startTime":"0","endTime":"0","summary":"美东时间2025年4月25日,安进成交额为5.59亿美元,成交额较昨日减少11.47%,当日成交量为199.46万股。安进于2025年4月25日涨0.36%,报280.84美元,该股过去5个交易日涨1.28%,年初至今涨8.62%,过去60日涨0.51%。安进于 2006 年推出了首款癌症治疗药物 Vectibix,并销售骨强化药物 Prolia/Xgeva和 Evenity。同时,安进还拥有不断增长的生物仿制药产品组合。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250426091609a4678431&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250426091609a4678431&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4534","LU2242652126.USD","BK4139","LU0289739699.SGD","LU2242646821.SGD","IE00BFTCPJ56.SGD","BK4581","LU0058720904.USD","BK4588","LU1023059063.AUD","LU0868494617.USD","LU1983299246.USD","BK4585","IE00B4R5TH58.HKD","BK4566","BK4599","LU0122379950.USD","LU0889565916.HKD","SG9999001440.SGD","IE0009355771.USD","BK4533","AMGN","LU0109394709.USD","IE0002141913.USD","LU1571399168.USD","LU2112291526.USD","LU2468319806.SGD","IE00B2B36J28.USD","LU1061106388.HKD","LU0320765992.SGD","IE00BJT1NW94.SGD","IE00BJJMRZ35.SGD","LU1057294990.SGD","LU2089984988.USD"],"gpt_icon":0},{"id":"2529591552","title":"安进4月22日成交额为5.77亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529591552","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529591552?lang=zh_cn&edition=full","pubTime":"2025-04-23 09:15","pubTimestamp":1745370948,"startTime":"0","endTime":"0","summary":"美东时间2025年4月22日,安进成交额为5.77亿美元,成交额较昨日增加16.93%,当日成交量为208.10万股。安进于2025年4月22日涨1.72%,报278.4美元,该股过去5个交易日跌5.28%,年初至今涨7.68%,过去60日涨1.9%。安进于 2006 年推出了首款癌症治疗药物 Vectibix,并销售骨强化药物 Prolia/Xgeva和 Evenity。同时,安进还拥有不断增长的生物仿制药产品组合。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423091602a6c47862&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423091602a6c47862&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BFTCPJ56.SGD","BK4599","LU1571399168.USD","IE00B4R5TH58.HKD","BK4139","LU1983299246.USD","LU0320765992.SGD","BK4581","AMGN","LU0058720904.USD","LU2468319806.SGD","LU0109394709.USD","LU2089984988.USD","LU0289739699.SGD","IE0002141913.USD","LU1023059063.AUD","IE00BJJMRZ35.SGD","LU1061106388.HKD","BK4585","LU0889565916.HKD","LU2112291526.USD","BK4566","LU2242646821.SGD","LU0122379950.USD","IE00BJT1NW94.SGD","IE0009355771.USD","IE00B2B36J28.USD","LU2242652126.USD","BK4588","BK4534","SG9999001440.SGD","LU0868494617.USD","BK4533","LU1057294990.SGD"],"gpt_icon":0},{"id":"2529236157","title":"安进4月21日成交额为4.94亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529236157","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529236157?lang=zh_cn&edition=full","pubTime":"2025-04-22 09:15","pubTimestamp":1745284547,"startTime":"0","endTime":"0","summary":"美东时间2025年4月21日,安进成交额为4.94亿美元,成交额较昨日减少58.99%,当日成交量为180.36万股。安进于2025年4月21日跌1.3%,报273.68美元,该股过去5个交易日跌4.3%,年初至今涨5.85%,过去60日跌0.72%。安进于 2006 年推出了首款癌症治疗药物 Vectibix,并销售骨强化药物 Prolia/Xgeva和 Evenity。同时,安进还拥有不断增长的生物仿制药产品组合。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422091557a461bb7c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422091557a461bb7c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1983299246.USD","IE00BJJMRZ35.SGD","BK4599","BK4581","LU1023059063.AUD","IE0002141913.USD","LU2242652126.USD","LU2242646821.SGD","LU0058720904.USD","LU0889565916.HKD","LU2468319806.SGD","IE00B2B36J28.USD","BK4585","LU0320765992.SGD","LU0868494617.USD","LU0122379950.USD","BK4588","IE00B4R5TH58.HKD","BK4566","IE0009355771.USD","LU1571399168.USD","LU2112291526.USD","BK4139","AMGN","LU2089984988.USD","BK4534","BK4533","IE00BJT1NW94.SGD","LU1061106388.HKD","LU0109394709.USD","SG9999001440.SGD","LU1057294990.SGD","LU0289739699.SGD","IE00BFTCPJ56.SGD"],"gpt_icon":0},{"id":"2527409934","title":"安进4月15日成交额为7.64亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527409934","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527409934?lang=zh_cn&edition=full","pubTime":"2025-04-16 09:15","pubTimestamp":1744766148,"startTime":"0","endTime":"0","summary":"美东时间2025年4月15日,安进成交额为7.64亿美元,成交额较昨日增加4.95%,当日成交量为259.36万股。安进于2025年4月15日涨0.47%,报295.3美元,该股过去5个交易日涨5.37%,年初至今涨14.21%,过去60日涨9.4%。安进于 2006 年推出了首款癌症治疗药物 Vectibix,并销售骨强化药物 Prolia/Xgeva和 Evenity。同时,安进还拥有不断增长的生物仿制药产品组合。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250416091610a45a622e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250416091610a45a622e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0868494617.USD","BK4585","LU0889565916.HKD","LU0320765992.SGD","LU0109394709.USD","LU1571399168.USD","LU2112291526.USD","LU1983299246.USD","IE00B4R5TH58.HKD","LU0058720904.USD","IE00BJT1NW94.SGD","LU1061106388.HKD","BK4533","LU1023059063.AUD","IE0002141913.USD","LU0122379950.USD","LU2468319806.SGD","IE00B2B36J28.USD","LU0289739699.SGD","LU2242646821.SGD","SG9999001440.SGD","BK4599","LU2089984988.USD","BK4588","IE00BFTCPJ56.SGD","BK4581","AMGN","LU2242652126.USD","IE00BJJMRZ35.SGD","BK4139","BK4534","IE0009355771.USD","LU1057294990.SGD","BK4566"],"gpt_icon":0},{"id":"2527172422","title":"安进4月14日成交额为7.28亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527172422","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527172422?lang=zh_cn&edition=full","pubTime":"2025-04-15 09:15","pubTimestamp":1744679747,"startTime":"0","endTime":"0","summary":"美东时间2025年4月14日,安进成交额为7.28亿美元,成交额较昨日减少26.10%,当日成交量为249.30万股。安进于2025年4月14日涨2.78%,报293.92美元,该股过去5个交易日涨1.46%,年初至今涨13.68%,过去60日涨9.97%。安进于 2006 年推出了首款癌症治疗药物 Vectibix,并销售骨强化药物 Prolia/Xgeva和 Evenity。同时,安进还拥有不断增长的生物仿制药产品组合。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415091604a4591a97&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415091604a4591a97&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4534","BK4585","LU1023059063.AUD","LU1061106388.HKD","SG9999001440.SGD","AMGN","BK4139","LU2242646821.SGD","LU2242652126.USD","BK4581","BK4599","IE00BJJMRZ35.SGD","LU0058720904.USD","LU0122379950.USD","BK4533","LU1571399168.USD","BK4566","LU0289739699.SGD","IE00BJT1NW94.SGD","LU2468319806.SGD","IE00B4R5TH58.HKD","LU1983299246.USD","IE0002141913.USD","LU1057294990.SGD","LU0109394709.USD","LU0889565916.HKD","IE00BFTCPJ56.SGD","LU2112291526.USD","IE0009355771.USD","LU0320765992.SGD","LU2089984988.USD","IE00B2B36J28.USD","LU0868494617.USD","BK4588"],"gpt_icon":0},{"id":"2527912372","title":"瑞银:维持Amgen(AMGN.US)评级,由中性调整至中性评级, 目标价由315.00美元调整至319.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2527912372","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527912372?lang=zh_cn&edition=full","pubTime":"2025-04-15 06:02","pubTimestamp":1744668124,"startTime":"0","endTime":"0","summary":"瑞银:维持Amgen(AMGN.US)评级,由中性调整至中性评级, 目标价由315.00美元调整至319.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/04/15060249537128.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["AMGN"],"gpt_icon":0},{"id":"2518276906","title":"安进盘中异动 股价大涨3.03%报334.69美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518276906","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518276906?lang=zh_cn&edition=full","pubTime":"2025-03-10 22:12","pubTimestamp":1741615977,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日22时12分,安进股票出现波动,股价大幅拉升3.03%。截至发稿,该股报334.69美元/股,成交量58.2511万股,换手率0.11%,振幅3.63%。最近的财报数据显示,该股实现营业收入332.32亿美元,净利润40.90亿美元,每股收益7.62美元,毛利213.33亿美元,市盈率44.26倍。安进股票所在的制药行业中,整体跌幅为1.58%。安进于 2006 年推出了首款癌症治疗药物 Vectibix,并销售骨强化药物 Prolia/Xgeva和 Evenity。同时,安进还拥有不断增长的生物仿制药产品组合。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031022125896404054&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031022125896404054&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1023059063.AUD","LU0058720904.USD","BK4533","IE0002141913.USD","LU2112291526.USD","BK4139","SG9999001440.SGD","LU0122379950.USD","LU2242646821.SGD","AMGN","BK4588","LU0320765992.SGD","IE00B2B36J28.USD","BK4585","IE00B4R5TH58.HKD","LU0109394709.USD","LU1061106388.HKD","IE00BJT1NW94.SGD","IE0009355771.USD","IE00BFTCPJ56.SGD","LU0868494617.USD","BK4566","BK4534","LU2242652126.USD","BK4581","BK4599","LU0289739699.SGD","LU1571399168.USD","IE00BJJMRZ35.SGD","LU0889565916.HKD","LU1057294990.SGD","LU1983299246.USD"],"gpt_icon":0},{"id":"2517442358","title":"【安进:Rocatinlimab治疗中重度特应性皮炎研究达到共同主要终点】 3月8日,安进公司与协和麒麟株式会社公布了ROCKET III期临床试验项目的最新结果。该项目正在评估rocatinlimab用于治疗中重度特应性皮炎的疗效。IGNITE研究评估了rocatinlimab的两种剂量强度,达到了共同主要终点和所有关键次要终点,两种剂量组相较于安慰剂组均显示出统计学显著差异。","url":"https://stock-news.laohu8.com/highlight/detail?id=2517442358","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517442358?lang=zh_cn&edition=full","pubTime":"2025-03-08 22:00","pubTimestamp":1741442455,"startTime":"0","endTime":"0","summary":"3月8日,安进公司与协和麒麟株式会社公布了ROCKET III期临床试验项目的最新结果。该项目正在评估rocatinlimab用于治疗中重度特应性皮炎的疗效。IGNITE研究评估了rocatinlimab的两种剂量强度,达到了共同主要终点和所有关键次要终点,两种剂量组相较于安慰剂组均显示出统计学显著差异。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/08220048611823.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LU0320765992.SGD","LU1061106388.HKD","LU2242646821.SGD","IE00B2B36J28.USD","03347","BK4588","BK4534","IE00BJT1NW94.SGD","LU0109394709.USD","BK4139","IE0009355771.USD","BK4566","BK4581","BK4134","BK1141","LU0122379950.USD","IE0002141913.USD","LU1571399168.USD","LU0058720904.USD","BK4599","LU1983299246.USD","LU2242652126.USD","BK4585","IE00B4R5TH58.HKD","LU1023059063.AUD","AMGN","LU0289739699.SGD","IE00BJJMRZ35.SGD","LU0889565916.HKD","SG9999001440.SGD","III","BK1576","LU2112291526.USD","LU0868494617.USD","BK4533","BK1583","LU1057294990.SGD","IE00BFTCPJ56.SGD"],"gpt_icon":0},{"id":"2517448458","title":"医药生物行业专题:海外制药企业2024Q4&全年业绩回顾","url":"https://stock-news.laohu8.com/highlight/detail?id=2517448458","media":"国信证券股份有...","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517448458?lang=zh_cn&edition=full","pubTime":"2025-03-07 20:14","pubTimestamp":1741349673,"startTime":"0","endTime":"0","summary":"代谢:诺和诺德Ozempic+Wegovy+Rybelsus 2024年合计销售~293亿美元,礼来Mounjaro+Zepbound合计销售~165亿美元;美国降糖相关GLP-1总处方量增速15%+,2025年初减重GLP-1周度处方量较2024年初增长 ~3x。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307201454989fd3c6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307201454989fd3c6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1718418525.SGD","LU1551013342.USD","AMGN","LU1934455194.USD","IE00BFTCPJ56.SGD","LU2237443382.USD","LU0211328371.USD","LU1267930490.SGD","LU0912757837.SGD","LU1989772923.USD","LU0795875169.SGD","IE00B4R5TH58.HKD","LU2468319806.SGD","LU2237443465.HKD","BK4139","LU1037948541.HKD","LU2237443978.SGD","LU2237443622.USD","LU0553294199.USD","LU0310799852.SGD","LU1037948897.HKD","LU1496350502.SGD","IE00BDGV0183.EUR","IE00B42XCP33.USD","LU0170899867.USD","LU1244550221.USD","LU1732800096.USD","LU1093756168.USD","LLY","BK4566","LU1023059063.AUD","LU1430594728.SGD","LU1585245621.USD","LU0738911758.USD","LU2237443549.SGD","BK4559","LU0820561909.HKD","ABBV","LU0256863811.USD","LU0985320562.USD","LU1244550494.USD","LU1267930573.SGD","LU1003077747.HKD","LU1291159041.SGD","LU0949170772.SGD","LU1732799900.SGD","IE0002141913.USD","LU0965509101.SGD","LU0965509283.SGD","AZN","LU0256863902.USD","LU0122379950.USD","IE0004445239.USD"],"gpt_icon":0},{"id":"2517175213","title":"安进(AMGN.US)AMG 133启动减重III期临床","url":"https://stock-news.laohu8.com/highlight/detail?id=2517175213","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517175213?lang=zh_cn&edition=full","pubTime":"2025-03-07 15:29","pubTimestamp":1741332593,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,3月5日,全球临床试验收录网站clinicaltrials显示,安进启动了AMG 133的两项III期临床试验,标志着AMG 133进入III期开发阶段。AMG133是安进自主研发的一款注射频率可达到每4周1次的first-in-class抗体多肽偶联药物,由靶向葡萄糖依赖性促胰岛素释放多肽受体的全人源单抗偶联两个GLP-1类似物而成,通过抑制GIPR并激活GLP-1受体来发挥减少食物摄入和调节代谢进而减轻体重和降低血糖的作用。AMG 133的降糖和减重效果已经在II期研究中得到了初步验证。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1258992.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4566","IE00BJJMRZ35.SGD","IE00B4R5TH58.HKD","SG9999001440.SGD","IE00BJT1NW94.SGD","LU2242652126.USD","BK4505","IE00B2B36J28.USD","AMGN","LU0289739699.SGD","BK4135","BK4588","LU1023059063.AUD","LU1983299246.USD","LU0320765992.SGD","BK4134","LU1061106388.HKD","IE00BFTCPJ56.SGD","BK4585","IE0002141913.USD","BK4599","LU0889565916.HKD","LU1571399168.USD","BK4533","AMG","III","IE0009355771.USD","LU0122379950.USD","LU2242646821.SGD","LU1057294990.SGD","BK4139","LU0058720904.USD","LU2112291526.USD","BK4534","LU0868494617.USD","LU0109394709.USD","BK4581"],"gpt_icon":0},{"id":"2517276311","title":"首个肿瘤mRNA疫苗有望在2027年推出;安进减肥药启动III期临床","url":"https://stock-news.laohu8.com/highlight/detail?id=2517276311","media":"Ofweek光电信息网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517276311?lang=zh_cn&edition=full","pubTime":"2025-03-07 14:09","pubTimestamp":1741327740,"startTime":"0","endTime":"0","summary":"mRNA肿瘤疫苗的重磅节点,可能近了。安进继续押注减肥药。/ 05 / 海外药闻1)首个肿瘤mRNA疫苗有望在2027年推出3月5日,Moderna在投资者会议上表示,该公司有望于2027年推出首个mRNA肿瘤疫苗V940。2)安进AMG 133启动减重III期临床3月5日,据全球临床试验收录网站clinicaltrials,安进启动了AMG 133的两项减重III期临床试验,标志着AMG 133进入III期开发阶段。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307141635989f7805&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307141635989f7805&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4566","IE00BJJMRZ35.SGD","IE00B4R5TH58.HKD","SG9999001440.SGD","IE00BJT1NW94.SGD","LU2242652126.USD","IE00B2B36J28.USD","AMGN","LU0289739699.SGD","BK4588","LU1023059063.AUD","LU1983299246.USD","LU0320765992.SGD","BK4134","LU1061106388.HKD","IE00BFTCPJ56.SGD","BK4585","IE0002141913.USD","BK4599","LU0889565916.HKD","LU1571399168.USD","BK4533","III","IE0009355771.USD","LU0122379950.USD","LU2242646821.SGD","LU1057294990.SGD","BK4139","LU0058720904.USD","LU2112291526.USD","BK4534","LU0868494617.USD","LU0109394709.USD","BK4581"],"gpt_icon":0},{"id":"2517013632","title":"每月1针!安进AMG 133启动减重III期临床","url":"https://stock-news.laohu8.com/highlight/detail?id=2517013632","media":"医药魔方","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517013632?lang=zh_cn&edition=full","pubTime":"2025-03-06 16:50","pubTimestamp":1741251040,"startTime":"0","endTime":"0","summary":"3月5日,全球临床试验收录网站clinicaltrials显示,安进启动了AMG 133的两项III期临床试验,标志着AMG 133进入III期开发阶段。MARITIME-2是一项随机、双盲、安慰剂对照临床试验,旨在评估AMG 133在伴2型糖尿病的肥胖或超重成人患者中的有效性、安全性和耐受性。AMG 133的降糖和减重效果已经在II期研究中得到了初步验证。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306165532abeb1222&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306165532abeb1222&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4581","LU0889565916.HKD","LU0109394709.USD","IE00BJT1NW94.SGD","LU0058720904.USD","AMGN","BK4599","LU1057294990.SGD","IE00B2B36J28.USD","SG9999001440.SGD","BK4585","LU2112291526.USD","BK4566","IE0002141913.USD","LU2242652126.USD","LU0289739699.SGD","BK4534","LU1571399168.USD","LU1061106388.HKD","LU0868494617.USD","BK4533","AMG","LU2242646821.SGD","IE00BJJMRZ35.SGD","BK4139","BK4505","III","LU0320765992.SGD","BK4588","IE00B4R5TH58.HKD","IE0009355771.USD","LU0122379950.USD","LU1023059063.AUD","IE00BFTCPJ56.SGD","LU1983299246.USD","BK4134","BK4135"],"gpt_icon":0},{"id":"1198097071","title":"美银证券分析师:强生等五支生物制药股可能会蓄势突破","url":"https://stock-news.laohu8.com/highlight/detail?id=1198097071","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1198097071?lang=zh_cn&edition=full","pubTime":"2025-03-06 11:29","pubTimestamp":1741231784,"startTime":"0","endTime":"0","summary":"美国银行证券分析师Tim Anderson认为,一批生物制药领域的\"大块头\"或迎来机遇。截至周二,这五支股票在该机构覆盖的大型生物制药股中涨幅居前。分析师指出,公司收入稳定性强、每股收益长期增长,且市盈率处于行业平均水平。尽管本周启动两项后期试验,Anderson认为该药\"可能继续令人失望\",但若商业表现超预期仍有上涨空间。分析师指出其估值溢价可能被市场忽视,在行业动荡期被视为\"避风港\",且医疗科技业务独具优势。","market":"us","thumbnail":"https://static.tigerbbs.com/3153c88188d79bb8182b93c4fdd43636","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/3153c88188d79bb8182b93c4fdd43636"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"美银证券分析师:强生等五支生物制药股可能会蓄势突破","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABBV","GILD","AMGN","LLY","JNJ"],"gpt_icon":1},{"id":"2517401509","title":"B of A Securities:维持Amgen(AMGN.US)评级,由低于大市调整至低于大市评级, 目标价由275.00美元调整至294.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2517401509","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517401509?lang=zh_cn&edition=full","pubTime":"2025-03-06 02:12","pubTimestamp":1741198339,"startTime":"0","endTime":"0","summary":"B of A Securities:维持Amgen(AMGN.US)评级,由低于大市调整至低于大市评级, 目标价由275.00美元调整至294.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/06021248550885.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["AMGN"],"gpt_icon":0},{"id":"2514350322","title":"百济神州,正在走安进曾经的路","url":"https://stock-news.laohu8.com/highlight/detail?id=2514350322","media":"医曜","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514350322?lang=zh_cn&edition=full","pubTime":"2025-02-28 07:28","pubTimestamp":1740698880,"startTime":"0","endTime":"0","summary":"随着百济神州2024年财报的披露,其再次向市场深化了“创新药一哥”的定位。无论是市值规模,还是产品成熟度,百济神州显然与安进都不是一个等级的对手,简单静态对比并不能得出什么有效结论。如果以此视角推测,虽然不能说百济神州估值过高,但也应警惕如当年安进估值回落盘整的风险。如果说百济神州正在走安进曾经的路,那么长达十二年的潜在瓶颈期才是最考验投资者认知的。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022808161998958181&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022808161998958181&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AMGN","IE00BJT1NW94.SGD","LU0868494617.USD","IE00BFTCPJ56.SGD","LU2242646821.SGD","LU0109394709.USD","ONC","IE00B4R5TH58.HKD","LU1057294990.SGD","SG9999001440.SGD","BK4585","BK4139","BK4581","LU0058720904.USD","BK4588","LU0289739699.SGD","LU1571399168.USD","LU1023059063.AUD","BK4566","BK4533","BK4534","LU0320765992.SGD","LU2242652126.USD","IE00B2B36J28.USD","06160","BK4599","IE0009355771.USD","LU2112291526.USD","IE0002141913.USD","LU0889565916.HKD","LU1061106388.HKD","LU1983299246.USD","LU0122379950.USD","IE00BJJMRZ35.SGD"],"gpt_icon":0},{"id":"2514286547","title":"安进盘中异动 股价大跌3.00%报306.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514286547","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514286547?lang=zh_cn&edition=full","pubTime":"2025-02-27 01:56","pubTimestamp":1740592595,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日01时56分,安进股票出现波动,股价大幅跳水3.00%。截至发稿,该股报306.15美元/股,成交量127.737万股,换手率0.24%,振幅2.34%。最近的财报数据显示,该股实现营业收入332.32亿美元,净利润40.90亿美元,每股收益7.62美元,毛利213.33亿美元,市盈率40.51倍。安进股票所在的制药行业中,整体跌幅为0.22%。安进于 2006 年推出了首款癌症治疗药物 Vectibix,并销售骨强化药物 Prolia/Xgeva和 Evenity。同时,安进还拥有不断增长的生物仿制药产品组合。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227015635963175b4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227015635963175b4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1061106388.HKD","LU1057294990.SGD","SG9999001440.SGD","LU1571399168.USD","BK4581","LU0058720904.USD","IE00BFTCPJ56.SGD","BK4139","LU0122379950.USD","LU0109394709.USD","LU2112291526.USD","LU0289739699.SGD","LU0868494617.USD","LU1023059063.AUD","IE0009355771.USD","LU2242652126.USD","BK4585","BK4566","IE00BJJMRZ35.SGD","LU0889565916.HKD","AMGN","LU1983299246.USD","BK4534","LU2242646821.SGD","IE00B2B36J28.USD","LU0320765992.SGD","BK4599","IE00BJT1NW94.SGD","BK4533","IE00B4R5TH58.HKD","BK4588","IE0002141913.USD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.amgen.com","stockEarnings":[{"period":"1week","weight":0.0469},{"period":"1month","weight":-0.0662},{"period":"3month","weight":0.0243},{"period":"6month","weight":-0.0887},{"period":"1year","weight":0.062},{"period":"ytd","weight":0.1162}],"compareEarnings":[{"period":"1week","weight":0.0357},{"period":"1month","weight":-0.0087},{"period":"3month","weight":-0.0835},{"period":"6month","weight":-0.0289},{"period":"1year","weight":0.1047},{"period":"ytd","weight":-0.0538}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"安进公司于1980年在加利福尼亚成立,并于1987年成为特拉华州的一家公司。该公司发现、开发、制造和交付创新药物,以对抗世界上一些最棘手的疾病。该公司专注于高度未满足的医疗需求领域,并利用其专业知识努力寻求能够显著改善人们生活的解决方案,同时还能减轻疾病带来的社会和经济负担。该公司在40多年前帮助启动了生物技术产业,并已成长为世界领先的独立生物技术公司之一。","yearOnYearQuotes":[{"month":1,"riseRate":0.642857,"avgChangeRate":0.034093},{"month":2,"riseRate":0.47619,"avgChangeRate":-0.001155},{"month":3,"riseRate":0.52381,"avgChangeRate":0.019224},{"month":4,"riseRate":0.452381,"avgChangeRate":-0.002852},{"month":5,"riseRate":0.536585,"avgChangeRate":0.024998},{"month":6,"riseRate":0.512195,"avgChangeRate":0.004729},{"month":7,"riseRate":0.761905,"avgChangeRate":0.052458},{"month":8,"riseRate":0.619048,"avgChangeRate":0.005154},{"month":9,"riseRate":0.52381,"avgChangeRate":0.002807},{"month":10,"riseRate":0.52381,"avgChangeRate":0.020682},{"month":11,"riseRate":0.619048,"avgChangeRate":0.019128},{"month":12,"riseRate":0.642857,"avgChangeRate":0.047779}],"exchange":"NASDAQ","name":"安进","nameEN":"Amgen"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"安进(AMGN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供安进(AMGN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"安进,AMGN,安进股票,安进股票老虎,安进股票老虎国际,安进行情,安进股票行情,安进股价,安进股市,安进股票价格,安进股票交易,安进股票购买,安进股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"安进(AMGN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供安进(AMGN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}